OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions
Mild to Moderate Persistent Asthma
Interventions
DRUG

OC000459 or placebo

Pills, active and/or placebo given twice daily for 17 weeks

Trial Locations (6)

Unknown

Research site, Sofia

Research site, Győr

Research site, Warsaw

Research site, Bucharest

Research site, Moscow

Research site, Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Oxagen Ltd

INDUSTRY